688289 聖湘生物
按盤價 
17.900 -0.320 (-1.756%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.662 | 3.816 | 4.948 | 27.929 | 40.357 |
| 總資產報酬率 ROA (%) | 2.118 | 3.231 | 4.127 | 23.817 | 35.755 |
| 投入資產回報率 ROIC (%) | 2.311 | 3.627 | 4.845 | 27.468 | 39.555 | 邊際利潤分析 |
| 銷售毛利率 (%) | 72.976 | 77.912 | 71.539 | 58.834 | 71.668 |
| 營業利潤率 (%) | 15.859 | 19.051 | 42.444 | 36.274 | 58.074 |
| 息稅前利潤/營業總收入 (%) | 10.485 | 12.024 | 35.450 | 35.123 | 58.206 |
| 淨利潤/營業總收入 (%) | 13.019 | 15.519 | 34.571 | 30.025 | 49.673 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 98.585 | 68.961 | 6.158 | 109.765 | 96.776 |
| 價值變動淨收益/利潤總額(%) | 5.133 | -7.842 | 76.881 | 3.422 | 3.097 |
| 營業外收支淨額/利潤總額(%) | -9.753 | -6.587 | -4.138 | -1.031 | -0.213 | 償債能力分析 |
| 流動比率 (X) | 4.876 | 7.670 | 6.473 | 4.788 | 8.986 |
| 速動比率 (X) | 4.487 | 7.150 | 6.063 | 4.562 | 8.430 |
| 資產負債率 (%) | 23.711 | 14.622 | 12.175 | 18.106 | 10.000 |
| 帶息債務/全部投入資本 (%) | 16.891 | 5.847 | 1.050 | 0.483 | 0.949 |
| 股東權益/帶息債務 (%) | 482.495 | 1,587.020 | 9,285.780 | 20,361.485 | 10,364.053 |
| 股東權益/負債合計 (%) | 317.757 | 575.768 | 699.630 | 451.575 | 898.257 |
| 利息保障倍數 (X) | -2.645 | -2.056 | -6.679 | -44.984 | 227.525 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 138.442 | 150.476 | 351.351 | 57.791 | 52.447 |
| 存貨周轉天數 (天) | 327.777 | 430.019 | 459.635 | 49.133 | 90.945 |
| 備註： | 即時報價更新時間為 17/04/2026 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
